HomeCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Nakaraang pagsara
$7.33
Sakop ng taon
$5.25 - $22.20
Market cap
2.03M USD
Average na Volume
370.00
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
CNBC
17 oras ang nakalipas
Here are our trades of the week and what’s ahead for this overbought market
0.13%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.00K | -98.93% |
Gastos sa pagpapatakbo | 3.65M | -42.11% |
Net na kita | -3.26M | 40.22% |
Net profit margin | -81.42K | -5,474.80% |
Kita sa bawat share | -0.72 | 89.09% |
EBITDA | -3.64M | 38.49% |
Aktuwal na % ng binabayarang buwis | 11.23% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.00M | -40.97% |
Kabuuang asset | 8.19M | -50.19% |
Kabuuang sagutin | 7.19M | -36.40% |
Kabuuang equity | 999.00K | — |
Natitirang share | 1.97M | — |
Presyo para makapag-book | 13.33 | — |
Return on assets | -126.92% | — |
Return on capital | 1,542.76% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.26M | 40.22% |
Cash mula sa mga operasyon | -3.08M | -136.32% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 6.29M | 12,431.37% |
Net change in cash | 3.20M | 351.93% |
Malayang cash flow | -2.94M | -93.08% |
Tungkol
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
Itinatag
Ago 13, 1996
Headquarters
Website
Mga Empleyado
12
